These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17094773)

  • 41. Treatment of bile acid malabsorption using ileal stem cell transplantation.
    Avansino JR; Chen DC; Hoagland VD; Woolman JD; Haigh WG; Stelzner M
    J Am Coll Surg; 2005 Nov; 201(5):710-20. PubMed ID: 16256913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated serotonin associated with collagenous colitis.
    Docherty M
    Am J Gastroenterol; 2010 Jun; 105(6):1449. PubMed ID: 20523322
    [No Abstract]   [Full Text] [Related]  

  • 43. Efficacy of budesonide in collagenous colitis Evaluation of: Miehlke S, Madisch A, Kupcinskas L, et al. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis. Gastroenterology 2014;146(5):1222-1230 e1222.
    Drug VL; Antoniu SA
    Expert Opin Pharmacother; 2014 Oct; 15(15):2277-9. PubMed ID: 25164577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical course of collagenous colitis over a period of 10 years.
    Madisch A; Miehlke S; Lindner M; Bethke B; Stolte M
    Z Gastroenterol; 2006 Sep; 44(9):971-4. PubMed ID: 16981069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial.
    Miehlke S; Heymer P; Bethke B; Bästlein E; Meier E; Bartram HP; Wilhelms G; Lehn N; Dorta G; DeLarive J; Tromm A; Bayerdörffer E; Stolte M
    Gastroenterology; 2002 Oct; 123(4):978-84. PubMed ID: 12360457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Locally acting corticosteroids in microscopic colitis: are they the treatment of choice? How should they be used?].
    Marín-Jiménez I; Yepes Barreto I
    Gastroenterol Hepatol; 2008 Sep; 31 Suppl 3():22-6. PubMed ID: 19087860
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacokinetics and bone effects of budesonide in primary biliary cirrhosis.
    Rautiainen H; Färkkilä M; Neuvonen M; Sane T; Karvonen AL; Nurmi H; Kärkkäinen P; Neuvonen PJ; Backman JT
    Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1545-52. PubMed ID: 17206943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploring possible mechanisms for primary bile acid malabsorption: evidence for different regulation of ileal bile acid transporter transcripts in chronic diarrhoea.
    Balesaria S; Pell RJ; Abbott LJ; Tasleem A; Chavele KM; Barley NF; Khair U; Simon A; Moriarty KJ; Brydon WG; Walters JR
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):413-22. PubMed ID: 18403943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Budesonide treatment of patients with collagenous colitis restores normal eosinophil and T-cell activity in the colon.
    Wagner M; Lampinen M; Sangfelt P; Agnarsdottir M; Carlson M
    Inflamm Bowel Dis; 2010 Jul; 16(7):1118-26. PubMed ID: 20027654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry.
    Camilleri M; Nadeau A; Tremaine WJ; Lamsam J; Burton D; Odunsi S; Sweetser S; Singh R
    Neurogastroenterol Motil; 2009 Jul; 21(7):734-e43. PubMed ID: 19368662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Linear mucosal defect may be characteristic of lansoprazole-associated collagenous colitis.
    Umeno J; Matsumoto T; Nakamura S; Jo Y; Yada S; Hirakawa K; Yoshimura R; Yamagata H; Kudo T; Hirano A; Gushima M; Yao T; Nakashima Y; Iida M
    Gastrointest Endosc; 2008 Jun; 67(7):1185-91. PubMed ID: 18513560
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pseudomembranous collagenous colitis with superimposed drug damage.
    Villanacci V; Cristina S; Muscarà M; Saettone S; Broglia L; Antonelli E; Salemme M; Occhipinti P; Bassotti G
    Pathol Res Pract; 2013 Nov; 209(11):735-9. PubMed ID: 24080283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NSAID-induced collagenous colitis.
    Milman N; Kraag G
    J Rheumatol; 2010 Nov; 37(11):2432-3. PubMed ID: 21041266
    [No Abstract]   [Full Text] [Related]  

  • 54. Collagenous colitis: Requirement for high-dose budesonide as maintenance treatment.
    Fernandez-Bañares F; Piqueras M; Guagnozzi D; Robles V; Ruiz-Cerulla A; Casanova MJ; Gisbert JP; Busquets D; Arguedas Y; Pérez-Aisa A; Fernández-Salazar L; Lucendo AJ;
    Dig Liver Dis; 2017 Sep; 49(9):973-977. PubMed ID: 28457904
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Collagenous Colitis Refractory to Budesonide: is the Upper Gastrointestinal Tract Involved?
    Agudo B; Calvo M; Abreu LE
    J Crohns Colitis; 2017 Mar; 11(3):384-385. PubMed ID: 27557639
    [No Abstract]   [Full Text] [Related]  

  • 56. Collagenous colitis: oral low-dose methotrexate for patients with difficult symptoms: long-term outcomes.
    Riddell J; Hillman L; Chiragakis L; Clarke A
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1589-93. PubMed ID: 17845686
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Maintenance treatment with budesonide 6 mg versus 9 mg once daily in patients with Crohn's disease in remission.
    de Jong DJ; Bac DJ; Tan G; de Boer SY; Grabowsky IL; Jansen JB; Greinwald R; Naber TH
    Neth J Med; 2007 Oct; 65(9):339-45. PubMed ID: 17954953
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral budesonide in the treatment of chronic refractory pouchitis.
    Gionchetti P; Rizzello F; Poggioli G; Pierangeli F; Laureti S; Morselli C; Tambasco R; Calabrese C; Campieri M
    Aliment Pharmacol Ther; 2007 May; 25(10):1231-6. PubMed ID: 17451569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An altered composition of the microbiome in microscopic colitis is driven towards the composition in healthy controls by treatment with budesonide.
    Rindom Krogsgaard L; Kristian Munck L; Bytzer P; Wildt S
    Scand J Gastroenterol; 2019 Apr; 54(4):446-452. PubMed ID: 31009268
    [No Abstract]   [Full Text] [Related]  

  • 60. Inhibition of the intestinal absorption of bile acids using cationic derivatives: mechanism and repercussions.
    Vicens M; Macias RI; Briz O; Rodriguez A; El-Mir MY; Medarde M; Marin JJ
    Biochem Pharmacol; 2007 Feb; 73(3):394-404. PubMed ID: 17134679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.